一个分子蓝图,以准ALK基因融合在质母细胞瘤
Stephen C Mack1,2, Kelsey C Bertrand2,3
1Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.
概括
无细胞淋巴瘤激酶 (ALK) 基因融合是婴儿质母细胞瘤 (GBM) 的关键驱动因素. 识别这些ALK重组有助于确定那些可以从向ALK疗法中受益的患者.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种复杂的大脑瘤,影响所有年龄组.
- 在先天性和婴儿GBM病例中,ALK基因融合特别普遍.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
11.2K
